SCHEMBL29544605

SCHEMBL29544605

Oc1ccnc2cc(Br)sc12

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SNCA P37840 2/20 0.35
▸ FLT1 P17948 1/20 0.33
▸ GRIN3B O60391 1/20 0.33
▸ GRIN1 Q05586 1/20 0.33
▸ GRIN2C Q14957 1/20 0.33
▸ NQO2 P16083 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ HSP90AA1 P07900 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21566290 1.00 SNCA (0.35) SNCAFLT1GRIN3BGRIN1GRIN2C
SCHEMBL105732 0.77 FLT1 (0.33) FLT1GRIN3BGRIN1GRIN2C
SCHEMBL15397430 0.77 RIPK2 (0.36) GRIN3BGRIN1GRIN2CKDM4E
SCHEMBL29767078 0.77 FLT1 (0.33) FLT1GRIN3BGRIN1GRIN2C
SCHEMBL29560181 0.74 NOS3 (0.35) GRIN3BGRIN1GRIN2CKDM4EMEN1
SCHEMBL22866543 0.74 NOS3 (0.35) GRIN3BGRIN1GRIN2CKDM4EMEN1
SCHEMBL31612698 0.73 GRIN3B (0.34) GRIN3BGRIN1GRIN2C
SCHEMBL13802202 0.69 HSD17B10 (0.47) MEN1HTTKMT2ASMN1; SMN2
SCHEMBL8268309 0.68 NISCH (0.35) FLT1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL1490718 0.67 ALK (0.50) KDM4EHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269756-B 4-Oxo-3, 4-dihydropyrido [3,4-D ] pyrimidine compounds that inhibit EIF4E 效应疗法股份有限公司 2024-05-14 — — CN disclosed
EP-3994139-A1 EIF4E-INHIBITING 4-OXO-3,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE COMPOUNDS Effector Therapeutics Inc. (US) 2022-05-11 — — EP disclosed
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 — — WO disclosed
CN-114269756-A 4-oxo-3, 4-dihydropyrido [3,4-D ] pyrimidine compounds inhibiting EIF4E 效应疗法股份有限公司 2022-04-01 — — CN disclosed
Send feedback